IBacillus Coagulans

Umxholo

• Inokwenzeka ukuba isebenze ...
• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

Bacillus coagulans luhlobo lweentsholongwane. Isetyenziswa ngokufanayo ne-lactobacillus kunye nezinye iiprobiotic njengeebhaktheriya "eziluncedo".

Abantu bathatha i-Bacillus coagulans yesifo esinganyangekiyo samathumbu (IBS), isifo sorhudo, igesi, usulelo lomoya, kunye nezinye iimeko ezininzi, kodwa abukho ubungqina benzululwazi obuxhasa ezi zinto zisetyenziswayo.

I-Bacillus coagulans ivelisa i-lactic acid kwaye ihlala ichazwa njenge-lactobacillus. Ngapha koko, ezinye iimveliso zorhwebo eziqukethe iBacillus coagulans ziyathengiswa njengeLactobacillus sporogenes. Ngokungafaniyo ne-lactic acid bacteria efana ne-lactobacillus okanye i-bifidobacteria, i-Bacillus coagulans yenza iintsholongwane. I-Spores yinto ebalulekileyo ekuxeleleni i-Bacillus coagulans ngaphandle kwezinye iintsholongwane ze-lactic acid.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe Iibhasile zeBacillus zezi zilandelayo:

Inokwenzeka ukuba isebenze ...

• Ingxaki yexesha elide yamathumbu amakhulu ebangela iintlungu zesisu (isifo esiswini esinokucaphuka okanye i-IBS). Uphando lwezonyango lubonisa ukuba ukuthatha i-Bacillus coagulans yonke imihla kangangeentsuku ezingama-56-90 kuphucula umgangatho wobomi kwaye kunciphise ukuqunjelwa, ukugabha, iintlungu zesisu, kunye nenani lokuhamba kwamathumbu kubantu abane-IBS. Olunye uphando lweklinikhi lubonisa ukuba ukuthatha imveliso ethile yendibaniselwano (iColinox, i-DMG Italia SRL) equlathe i-Bacillus coagulans kunye ne-simethicone kathathu mihla le kwiiveki ezi-4 kuphucula ukudumba nokungonwabi kubantu abane-IBS.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Ukunqongophala kwesibindi (i-cirrhosis). Abantu abane-cirrhosis yesibindi kunokwenzeka ukuba bakhulise usulelo olubizwa ngokuba yi-bacterial peritonitis, okanye i-SBP. Uphando lwakwangoko lubonisa ukuba ukuthatha indibaniselwano yeprobiotic ene-Bacillus coagulans kunye nezinye iibhaktiriya kathathu yonke imihla, kunye neyeza okanye i-norfloxacin, akuwunciphisi umngcipheko womntu wokuphuhlisa i-SBP.
• Ukuqunjelwa. Uphando lwakwangoko lubonisa ukuba ukuthatha i-Bacillus coagulans kabini imihla ngeeveki ezi-4 kunokuphucula iintlungu zesisu kunye nokungonwabi kubantu abathanda ukuqhina.
• Urhudo. Uphando lwakwangoko kwiintsana ezimalunga neenyanga ezi-6 ukuya kwezi-24 zobudala ezinesifo sohudo lubonisa ukuba ukuthatha i-Bacillus coagulans ukuya kwiintsuku ezi-5 akusinciphisi isifo sohudo. Kodwa ukuthatha i-Bacillus coagulans kubonakala ngathi kuphucula urhudo kunye nentlungu esiswini kubantu abadala.
• Urhudo olubangelwa yi-rotavirus. Uphando lwakwangoko kwiintsana ezisandul 'ukuzalwa lubonisa ukuba ukuthatha i-Bacillus coagulans yonke imihla unyaka omnye kunciphisa umngcipheko womntwana wokufumana urhudo lwe-rotavirus.
• Irhasi (ukuqunjelwa). Ubungqina bokuqala babantu abanegesi emva kokutya kubonisa ukuba ukuthatha isongezelelo esithile sokudibanisa esineeBacillus coagulans kunye nokudityaniswa kwee-enzymes mihla le kwiiveki ezi-4 akuphuculi ukuqunjelwa okanye igesi.
• Ukunyanzeliswa (dyspepsia). Uphando lwakwangoko lubonisa ukuba ukuthatha i-Bacillus coagulans yonke imihla iiveki ezisi-8 kunokunciphisa iimpawu zokuqunjelwa, ukubethelwa kunye nokungcamla okumuncu. Olunye uphando lubonisa ukuba ukuthatha i-Bacillus coagulans kabini imihla ngeeveki ezi-4 kunciphisa iintlungu zesisu kunye nokuqunjelwa.
• Ukukhula okuthe kratya kwebhaktheriya kumathumbu amancinci. Ubungqina bokuqala bubonisa ukuba ukusebenzisa imveliso ethile yeprobiotic (iLactol, iBioplus Life Sciences Pvt. Ltd.) enee-Bacillus coagulans kunye ne-fructo-oligosaccharides yonke imihla kangangeentsuku ezili-15 zenyanga nganye kwiinyanga ezi-6 zinokunciphisa iintlungu zesisu kunye negesi kubantu abaneentsholongwane ezinobungozi. emathunjini.
• Isifo samathambo (RA). Uphando lwakwangoko lubonisa ukuba ukuthatha i-Bacillus coagulans yonke imihla kangangeentsuku ezingama-60 ukongeza kunyango oluqhelekileyo kunokunciphisa iintlungu, kodwa akulinciphisi inani lamalungu abuhlungu okanye adumbileyo kubantu abane-RA. I-Bacillus coagulans nayo ayiphuculi amandla okwenza imisebenzi yokuphila kwabantu be-RA mihla le.
• Isifo esibi emathunjini kwiintsana ezingaphambi kwexesha (i-necrotizing enterocolitis okanye i-NEC). Iintsana ezizalwa kwangethuba kakhulu okanye ezinobunzima obuphantsi kakhulu zisengozini ephezulu yokufumana usulelo olubi emathunjini abizwa ngokuba yi-necrotizing enterocolitis. Uphando lwakwangoko kwezi ntsana lubonisa ukuba ukuthatha i-Bacillus coagulans yonke imihla de uphume esibhedlele akukuthinteli ukubetheka kwe-enterocolitis okanye ukufa. Nangona kunjalo, ukuthatha i-Bacillus coagulans kuyalonyusa inani leentsana ezikwaziyo ukukunyamezela ukutya.
• Ukwakha amanqatha esibindini kubantu abasela kancinci okanye bangaseli tywala (isifo sesibindi esinamafutha okanye i-NAFLD).
• Uthintelo lomhlaza.
• Usulelo lwe-gastrointestinal tract yi-bacteria ebizwa ngokuba yiClostridium difficile.
• Iingxaki zokugaya.
• Usulelo lokugaya olunokukhokelela kwizilonda (Helicobacter pylori okanye H. pylori).
• Ukomeleza inkqubo yomzimba yokuzikhusela.
• Ukuvuvukala kwexesha elide (ukuvuvukala) kwindawo yokugaya (isifo sesisu okanye isifo se-IBD).
• Usulelo lweendlela zomoya.
• Ezinye iimeko.

Ubungqina obungakumbi buyafuneka ukukala ii-Bacillus coagulans kwezi zinto zisetyenziswayo. Akukho lwazi lwaneleyo lokwazi ukuba iBacillus coagulans inokusebenza njani ngeenjongo zonyango. Olunye uphando lubonisa ukuba i-Bacillus coagulans inokunyusa ukusebenza kwamajoni omzimba kunye nokunciphisa iintsholongwane eziyingozi.

Xa kuthathwa ngomlomo: Bacillus coagulans kukuba UKHUSELEKO OLUNOKWENZEKA xa kuthathwa ngomlomo. Uphando lubonisa ukuba i-Bacillus coagulans ngeedosi zeebhiliyoni ezingama-2 zeekoloni ezenza iiyunithi (ii-CFUs) mihla le zingasetyenziswa ngokukhuselekileyo ukuya kuthi ga kwiinyanga ezintathu. Iidosi ezisezantsi zeCacillus coagulans ukuya kuthi ga kwi-100 yezigidi ze-CFU mihla le zinokusetyenziswa ngokukhuselekileyo ukuya kuthi ga kunyaka omnye.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: Akukho lwazi lwaneleyo oluthembekileyo malunga nokhuseleko lokuthatha i-Bacillus coagulans ukuba ukhulelwe okanye uncancisa. Hlala kwicala elikhuselekileyo kwaye uphephe ukusetyenziswa.

Abantwana: Bacillus coagulans kukuba UKHUSELEKO OLUNOKWENZEKA xa kuthathwa ngomlomo kwiintsana nasebantwaneni. Olunye uphando lubonakalisile ukuba i-Bacillus coagulans ukuya kuthi ga kwi-100 yezigidi zeekoloni ezenza iiyunithi (ii-CFUs) yonke imihla zingasetyenziswa ngokukhuselekileyo ziintsana kude kube ngunyaka omnye.

Iphakathi

Lumka ngale nhlanganisela.

Iziyobisi Antibiotic

Amayeza okubulala iintsholongwane asetyenziselwa ukunciphisa iintsholongwane eziyingozi emzimbeni. I-Antibiotics inokunciphisa ezinye iibhaktheriya emzimbeni. Ukuthatha i-antibiotics kunye ne-Bacillus coagulans kunokunciphisa izibonelelo ezinokubakho ze-Bacillus coagulans. Ukuthintela ukuhlangana okunokubakho, thatha iBacillus coagulans iimveliso ubuncinci iiyure ezi-2 ngaphambi okanye emva kwentsholongwane.

Amayeza anciphisa amajoni omzimba (i-Immunosuppressants)

Bacillus coagulans inokunyusa umsebenzi wamajoni omzimba. Ukuthatha i-Bacillus coagulans kunye namayeza anciphisa ukusebenza kwamajoni omzimba kunokunciphisa ukusebenza kwala mayeza.
Amanye amayeza anciphisa ukusebenza kwamajoni omzimba abandakanya i-azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, FK506 Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids) kunye nabanye.

Akukho kunxibelelana kwaziwayo kunye namayeza kunye nezongezo.

Akukho kunxibelelana kwaziwayo nokutya.

La machiza alandelayo afundwe kuphando lwezesayensi:

ABADALA

NGOMLOMO:

• Ukuphazamiseka kwexesha elide kwamathumbu amakhulu abangela iintlungu zesisu (isifo esiswini esinokucaphuka okanye i-IBS)I-Bacillus coagulans (iLactospore, iSabinsa Corporation) iiyunithi ezingama-2 ezigidi zekholoni (ii-CFUs) mihla le kangangeentsuku ezingama-90. Bacillus coagulans (GanedenBC30, Ganeden Biotech Inc.) Izigidi ezingama-300 ukuya kwi-2 yezigidigidi ze-CFU mihla le kwiiveki ezisibhozo. Imveliso yendibaniselwano ethile (iColinox, i-DMG Italia SRL) equlathe i-Bacillus coagulans kunye ne-simethicone isetyenzisiwe emva kwesidlo ngasinye kathathu mihla le kwiiveki ezi-4.

B. Coagulans, Bacillus Bacteria, Bacillus Probiotic, Bactéries Bacilles, Bactéries à Gram Positif Sporogènes, Bactérie Gram Positive en Forme de Bâtonnet, i-Gram Positive Spore-Forming Rod, L. Sporogenes, Lactobacillus Sporogenes, Lactobacillus Spobiosis, Ndiyila iLactobacillus.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. I-Kumar VV, iSudha KM, iBennur S, iDhanasekar KR. I-Bacillus coagulans ye-GBI-30,6086 enee-enzymes zokugaya ukutya ekuphuculeni indigestion kubemi be-geriatric. J Ukhathalelo lweeMithi ngePrim Prim. 2020; 9: 1108-1112. Jonga i-abstract.
2. Utshintsho CW, Chen MJ, Shih SC, et al. I-Bacillus coagulans (PROBACI) kunyango lokuqhinwa-okubonakalayo kokuphazamiseka kwesisu. Amayeza (iBaltimore). 2020; 99: e20098. Jonga i-abstract.
3. I-Soman RJ, i-Swamy MV. Umntu oza kuba nakho, ongenamsebenzi, ongaboniyo kabini, olawulwa yi-placebo, ohlola iqela kunye nokuvavanya ukusebenza kakuhle kunye nokukhuseleka kwe-SNZ TriBac, isihlanganisi esine-Bacillus probiotic yokudityaniswa kokungaziva kakuhle kwamathumbu. I-Int J yeColorectal Dis. Ngo-2019; 34: 1971-1978. Jonga i-abstract.
4. UAhabhari K, Saadati S, Yari Z, et al. Iziphumo zokuthotyelwa kweBacillus coagulans kwizigulana ezinesifo esingenamafutha sesibindi: Uvavanyo olungenamkhethe, olulawulwa yi-placebo, lonyango. Iiklinikhi zeZondlo ESPEN. 2020; 39: 53-60. Jonga i-abstract.
5. Intombazana C, iGupta AK. Ucwaningo lweklinikhi olulawulwayo, olungenelelo ngoncedo, olungenamkhethe, oluyimfama, olulawulwa yi-placebo ukuvavanya ukusebenza kunye nokhuseleko lwe-Bacillus coagulans LBSC kunyango lwesifo sorhudo esibuhlungu ngokungahambi kakuhle esiswini. I-Eur J Clin Pharmacol. 2019; 75: 21-31. Jonga i-abstract.
6. U-Hun L. Bacillus coagulans uphucule kakhulu iintlungu zesisu kunye nokuqunjelwa kwizigulana ezine-IBS. I-Postgrad Med 2009; 121: 119-24. Jonga i-abstract.
7. U-Yang OO, uKelesidis T, uCordova R, uKhanlou H.Ukuchaphazeleka kwintsholongwane ye-HIV-1 yosulelo olunganyangekiyo kwilingo elilawulwa yi-placebo elingaboniyo. I-AIDS Res Hum Retroviruses 2014; 30: 988-95. Jonga i-abstract.
8. UDutta P, uMitra U, uDutta S, et al. Uvavanyo lweklinikhi olulawulwa ngokungahleliwe lweLactobacillus sporogenes (iBacillus coagulans), esetyenziswa njengeprobiotic kunyango, kuhudo olunamanzi olunamandla ebantwaneni. Trop Med Int Health 2011; 16: 555-61. Jonga i-abstract.
9. I-Endres JR, uClewell A, uJade KA, et al. Uvavanyo lokhuseleko lokulungiselela ukubakho kweprobiotic yenoveli, iBacillus coagulans, njengesixhobo sokutya. Ukutya Chem Toxicol 2009; 47: 1231-8. Jonga i-abstract.
10. UKalman DS, uSchwartz HI, uAlvarez P, okqhubekayo. Umntu oza kuvavanywa, ongenamsebenzi, ongaboniyo kabini, olawulwa liqela elilinganayo-iqela elilinganayo leqela lokuvavanya iimpembelelo zemveliso esekwe kwi-Bacillus coagulans kwiimpawu zerhasi yamathumbu asebenzayo. I-BMC Gastroenterol 2009; 9: 85. Jonga i-abstract.
11. IDolin BJ. Iziphumo zokulungiswa kwe-Bacillus coagulans kwiimpawu zorhudo-ubukhulu becala isifo samathumbu. Iindlela zokuFumana i-Clin Clin Pharmacol 2009; 31: 655-9. Jonga i-abstract.
12. UMandel DR, u-Eichas K, uHolmes J. Bacillus coagulans: unyango olusebenzayo lokudambisa iimpawu zesifo samathambo ngokolingo olungenamkhethe, olulawulwayo. I-BMC yokuGqibezela enye iMed 2010; 10: 1. Jonga i-abstract.
13. I-Sari FN, i-Dizdar EA, i-Oguz S, okqhubekayo. Iiprobiotic zomlomo: I-Lactobacillus sporogenes yokuthintela i-necrotizing enterocolitis kwiintsana ezinesisindo esiphantsi kakhulu: ityala elingahleliwe, elilawulwayo. I-Eur J yeklinikhi yeNutr 2011; 65: 434-9. Jonga i-abstract.
14. URiazi S, uWirawan RE, uBadmaev V, uChikindas ML. Ukuchazwa kwe-lactosporin, inoveli ye-antimicrobial protein eveliswe nguBacillus coagulans ATCC 7050. J Appl Microbiol 2009; 106: 1370-7. Jonga i-abstract.
15. UPande C, uKumar A, uSarin SK. Ukongezwa kwee-probiotic kwi-norfloxacin akuphuculi ukusebenza ngokufanelekileyo kuthintelo lwe-bacterial peritonitis: isilingo esilawulwa ngokungalawulekiyo esilawulwa kabini. I-Eur J Gastroenterol Hepatol 2012; 24: 831-9. Jonga i-abstract.
16. UMajeed M, uNagabhushanam K, uNatarajan S, et al. I-Bacillus coagulans i-MTCC 5856 yokuncedisa kulawulo lwesifo sorhudo esibangela isifo samathumbu esinganyangekiyo: isifundo esiphindwe kabini esingacwangciswanga esilawulwa yi-placebo esilawulwayo. Isondlo J 2016; 15: 21. Jonga i-abstract.
17. UChandra RK. Iziphumo zeLactobacillus kwisehlo kunye nobukrakra besifo sorhudo esibukhali kwiintsana. Isifundo esinokubakho esilawulwa yindawo engaboniyo. Ukutya okunesondlo 2002; 22: 65-9.
18. UDe Vecchi E, Drago L.Lactobacillus sporogenes okanye iBacillus coagulans: ukungazazi kakuhle okanye ukubeka gwenxa amagama? I-Int J Probiotic Prebiotic 2006; 1: 3-10.
19. UJurenka JS. Bacillus coagulans: Monograph. Enye iMed Rev 2012; 17: 76-81. Jonga i-abstract.
20. Urgesi R, uCasale C, uPistelli R, et al. Uvavanyo olulawulwa ngokungekho mthethweni olwenziwe kabini ngokungaboniyo ngokusebenza kunye nokukhuseleka kombutho we-simethicone kunye neBacillus coagulans (Colinox) kwizigulana ezinesifo sesibindi. I-Eur Rev Med ye-Pharmacol Sci 2014; 18: 1344-53. Jonga i-abstract.
21. UKhalighi AR, uKhalighi MR, uBehdani R, et al. Ukuvavanya ukusebenza kweprobiotic kunyango kwizigulana ezinokukhula kwebacteria encinci (SIBO) - isifundo somqhubi. Indiya J Med Res. Unyaka ka-2014; 140: 604-8. Jonga i-abstract.
22. UCzaczyk K, Tojanowska K, Mueller A. Umsebenzi wokubola we-Bacillus coagulans ngokuchasene neFusarium sp. Umthetho weMicrobiol Pol 2002; 51: 275-83. Jonga i-abstract.
23. UDonskey CJ, uHoyen CK, uDas SM, et al. Iziphumo zokulawulwa kwe-Bacillus coagulans ngomlomo kuxinano lwe-vancomycin-resistant enterococci kwisitulo seempuku ezi koloni. I-Lett Appl Microbiol 2001; 33: 84-8. Jonga i-abstract.
24. IHyronimus B, Le Marrec C, i-Urdaci MC. I-Coagulin, i-bacteriocin-like inhibitory subtances eveliswe yi-Bacillus coagulans I4. J Appl Microbiol 1998; 85: 42-50. Jonga i-abstract.
25. Iiprobiotic zorhudo olunxulunyaniswa neentsholongwane. Ileta ka-Pharmacist / I-Prescriber's Letter 2000; 16: 160103.
26. UDuc LH, Hong HA, uBarbosa TM, et al. Iimpawu zeBacillus probiotic ezikhoyo ukuze zisetyenziswe ngabantu. Iappl Environ Microbiol 2004; 70: 2161-71. Jonga i-abstract.
27. IVelraeds MM, van der Mei HC, Reid G, Busscher HJ. Ukuthintela ukunamathela kokuqala kwe-uropathogenic Enterococcus faecalis yi-biosurfactants evela kwiLactobacillus yodwa. Iappl Environ Microbiol 1996; 62: 1958-63. Jonga i-abstract.
28. IMcGroarty JA. Ukusetyenziswa kweprobiotic kwe-lactobacilli kwisiqwengana somfazi somntu. I-FEMS Immunol Med Microbiol 1993; 6: 251-64. Jonga i-abstract.
29. Ukufumana uG, uBruce AW, Cook RL, et al. Iziphumo kwizityalo ze-urogenital zonyango lwe-antibiotic yosulelo lwe-urinary tract. I-Scand J ye-Dis 1990, 22: 43-7. Jonga i-abstract.

Ukuhlaziywa kokugqibela-12/04/2020